Special stent fails to beat standard for tricky heart blockage

NCT ID NCT03508219

Terminated Disease control Sponsor: ECRI bv Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a new type of stent (BiOSS LIM C) designed for blockages at the left main coronary artery fork. The trial enrolled 130 people with severe blockages. Unfortunately, the new stent did not work as well as the standard stent, and the study was stopped early.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BiOSS LIM C stent (a drug-coated stent for bifurcation blockages)
What this could lead to: If it had succeeded, this could have pointed toward a better treatment for complex left main coronary blockages.
What could go wrong: The trial was terminated early because the new stent was not as effective as the standard stent. This is an early-stage device study with limited participants, so results may not apply broadly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder coronary stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY STENOSIS

Contacts and locations

Locations

Research Centre FRA-001

Aix-en-Provence, France
Research Centre FRA-002

Saint-Denis, France
Research Centre FRA-003

Grenoble, France
Research Centre FRA-004

Bron, France
Research Centre ITA-001

Naples, Italy
Research Centre ITA-002

Ragusa, Italy
Research Centre ITA-003

Syracuse, Italy
Research Centre PL-001

Warsaw, Poland
Research Centre PL-002

Zabrze, Poland
Research Centre PL-003

Zabrze, Poland
Research Centre PL-004

Olsztyn, Poland
Research Centre PL-005

Poznan, Poland
Research Centre PL-006

Katowice, Poland
Research Centre PL-007

Krakow, Poland
Research Centre PL-008

Warsaw, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.